Loading data
CTNMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | 0 USD | 50 m USD |
| Research and development expense | 51.52 m USD | 38.42 m USD | 27.6 m USD |
| Operating profit | -68.06 m USD | -50.89 m USD | 16.08 m USD |
| Profit before tax | -60.14 m USD | -42.26 m USD | 23.17 m USD |
| Income tax expense | 0 USD | 0 USD | 450 k USD |
| Net income (reported basis) | -59.98 m USD | -42.26 m USD | 22.72 m USD |
| Net income attributable to common shareholders | — | -42.26 m USD | 3.15 m USD |
| Basic earnings per share | -2.17 USD/share | -2.18 USD/share | 1.36 USD/share |
| Diluted earnings per share | -2.17 USD/share | -2.18 USD/share | 0.08 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.